Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
Open accessThe DOI matches its Crossref record; 396 of the 396 references it cites were found in a registry or an index.
Abstract
In this narrative review, the biological/biochemical impact (toxicity) of a large array of known individual uremic retention solutes and groups of solutes is summarized. We classified these compounds along their physico-chemical characteristics as small water-soluble compounds or groups, protein bound compounds and middle molecules. All but one solute (glomerulopressin) affected at least one mechanism with the potential to contribute to the uremic syndrome. In general, several mechanisms were influenced for each individual solute or group of solutes, with some impacting up to 7 different biological systems of the 11 considered. The inflammatory, cardio-vascular and fibrogenic systems were those most frequently affected and they are one by one major actors in the high morbidity and mortality of CKD but also the mechanisms that have most frequently been studied. A scoring system was built with the intention to classify the reviewed compounds according to the experimental evidence of their toxicity (number of systems affected) and overall experimental and clinical evidence. Among the highest globally scoring solutes were 3 small water-soluble compounds [asymmetric dimethylarginine (ADMA); trimethylamine-N-oxide (TMAO); uric acid], 6 protein bound compounds or groups of protein bound compounds [advanced glycation end products (AGEs); p-cresyl sulfate; indoxyl sulfate; indole acetic acid; the kynurenines; phenyl acetic acid;] and 3 middle molecules [β2-microglobulin; ghrelin; parathyroid hormone). In general, more experimental data were provided for the protein bound molecules but for almost half of them clinical evidence was missing in spite of robust experimental data. The picture emanating is one of a complex disorder, where multiple factors contribute to a multisystem complication profile, so that it seems of not much use to pursue a decrease of concentration of a single compound.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 1×
“suggested a substantial link to cardio-vascular disease [70].”
BackgroundDialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
Mc Causland, F. R., Brunelli, S. M., & Waikar, S. S. (2013) · American Journal of Nephrology · doi:10.1159/000355958 · Cited by 2,690
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Prolactin: structure, function, and regulation of secretion
Freeman, M. E., Kanyicska, B., Lerant, A., & Nagy, G. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1523 · Cited by 2,457 · cited 2×
“, in maintenance of immune function, osmoregulation, suppression of angiogenesis and by extension possibly also in tumor genesis [480].”
BackgroundGut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351 · cited 1×
“Peptide YY is an anorexigen [469,470] and inhibitor of gastric motility [471].”
BackgroundAccumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
Advanced oxidation protein products as a novel marker of oxidative stress in uremia
Witko-Sarsat, V., Friedlander, M., Capeillère-Blandin, C., Nguyen-Khoa, T., Nguyen, A. T., Zingraff, J., Jungers, P., & Descamps-Latscha, B. (1996) · Kidney International · doi:10.1038/ki.1996.186 · Cited by 1,999
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
Eknoyan, G., Beck, G. J., Cheung, A. K., Daugirdas, J. T., Greene, T., Kusek, J. W., Allon, M., Bailey, J., Delmez, J. A., Depner, T. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021583 · Cited by 1,882
Review on uremic toxins: Classification, concentration, and interindividual variability
Vanholder, R., For the European Uremic Toxin Work Group (EUTox), De Smet, R., Glorieux, G., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., De Deyn, P. P., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00924.x · Cited by 1,720
Self-citationInhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604 · cited 1×
“Peptide YY is an anorexigen [469,470] and inhibitor of gastric motility [471].”
BackgroundThe role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review
Klok, M. D., Jakobsdottir, S., & Drent, M. L. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2006.00270.x · Cited by 1,442 · cited 1×
“Ghrelin is known as an orexigen playing a role in meal initiation [381] and as such seems to oppose the trend for malnutrition of most CKD patients.”
BackgroundYan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305 · cited 1×
“Hence, Macrophage CSF might be a key factor in inflammatory conditions [419], including CKD [420].”
BackgroundBucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Knight, E. L., Verhave, J. C., Spiegelman, D., Hillege, H. L., De Zeeuw, D., Curhan, G. C., & De Jong, P. E. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00517.x · Cited by 1,039
Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
The EVOLVE Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205624 · Cited by 971
Normal and Pathologic Concentrations of Uremic Toxins
Duranton, F., Cohen, G., De Smet, R., Rodriguez, M., Jankowski, J., Vanholder, R., & Argiles, A. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011121175 · Cited by 961
Self-citationFeig, D. I., Soletsky, B., & Johnson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.924 · Cited by 914
Schmidt, A. M., Hori, O., Chen, J. X., Li, J. F., Crandall, J., Zhang, J., Cao, R., Yan, S. D., Brett, J., & Stern, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118175 · Cited by 896
Witko-Sarsat, V., Friedlander, M., Khoa, T. N., Capeillère-Blandin, C., Nguyen, A. T., Canteloup, S., Dayer, J.-M., Jungers, P., Drüeke, T., & Descamps-Latscha, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2524 · Cited by 878
Ghrelin Strongly Stimulates Growth Hormone Release in Humans
Takaya, K., Ariyasu, H., Kanamoto, N., Iwakura, H., Yoshimoto, A., Harada, M., Mori, K., Komatsu, Y., Usui, T., Shimatsu, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7167 · Cited by 864 · cited 1×
“However, the molecule has also been linked to several other negative biological activities, such as restricted insulin release [382] and blunted insulin sensitivity [383], increases in triglyceride content in the liver [384], mitochondrial oxidative enzyme activities [384], anxiogenic response to stress [385], increas…”
BackgroundFactors other than glomerular filtration rate affect serum cystatin C levels
Stevens, L. A., Schmid, C. H., Greene, T., Li, L., Beck, G. J., Joffe, M. M., Froissart, M., Kusek, J. W., Zhang, Y. (., Coresh, J., et al. (2009) · Kidney International · doi:10.1038/ki.2008.638 · Cited by 809
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
Tsai, J. C., Perrella, M. A., Yoshizumi, M., Hsieh, C. M., Haber, E., Schlegel, R., & Lee, M. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6369 · Cited by 798
Kanellis, J., Watanabe, S., Li, J. H., Kang, D. H., Li, P., Nakagawa, T., Wamsley, A., Sheikh-Hamad, D., Lan, H. Y., Feng, L., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000072820.07472.3b · Cited by 786
Renal filtration, transport, and metabolism of low-molecular-weight proteins: A review
Maack, T., Johnson, V., Kau, S. T., Figueiredo, J., & Sigulem, D. (1979) · Kidney International · doi:10.1038/ki.1979.128 · Cited by 766
Corry, D. B., Eslami, P., Yamamoto, K., Nyby, M. D., Makino, H., & Tuck, M. L. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f240bf · Cited by 751
Maduell, F., Moreso, F., Pons, M., Ramos, R., Mora-Macià, J., Carreras, J., Soler, J., Torres, F., Campistol, J. M., & Martinez-Castelao, A. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012080875 · Cited by 736
Huo, Y., Li, J., Qin, X., Huang, Y., Wang, X., Gottesman, R. F., Tang, G., Wang, B., Chen, D., He, M., et al. (2015) · JAMA · doi:10.1001/jama.2015.2274 · Cited by 731
Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35
Wang, J., Simonavicius, N., Wu, X., Swaminath, G., Reagan, J., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603503200 · Cited by 687
The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl Sulfate: A Systematic Review
Vanholder, R., Schepers, E., Pletinck, A., Nagler, E. V., & Glorieux, G. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013101062 · Cited by 683
Self-citationThe natural polyamine spermine functions directly as a free radical scavenger
Ha, H. C., Sirisoma, N. S., Kuppusamy, P., Zweier, J. L., Woster, P. M., & Casero, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11140 · Cited by 675
Quinolinic acid, the inescapable neurotoxin
Guillemin, G. J. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08485.x · Cited by 595 · cited 2×
“It contributes to the inhibition of erythropoiesis [285] and neurotoxicity [286].”
BackgroundCochat, P., & Rumsby, G. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1301564 · Cited by 586
Potential role and therapeutic interests of myo-inositol in metabolic diseases
Croze, M. L., & Soulage, C. O. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.011 · Cited by 578
Raggi, P., Chertow, G. M., Torres, P. U., Csiky, B., Naso, A., Nossuli, K., Moustafa, M., Goodman, W. G., Lopez, N., Downey, G., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq725 · Cited by 574
Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine
Valkonen, V.-P., Päivä, H., Salonen, J. T., Lakka, T. A., Lehtimäki, T., Laakso, J., & Laaksonen, R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07184-7 · Cited by 562 · cited 1×
“ADMA concentration has been linked to cardio-vascular events or mortality in the general population [36,37], as well as in CKD [38,39].”
BackgroundRobinson, K., Arheart, K., Refsum, H., Brattström, L., Boers, G., Ueland, P., Rubba, P., Palma-Reis, R., Meleady, R., Daly, L., et al. (1998) · Circulation · doi:10.1161/01.cir.97.5.437 · Cited by 550
Saran, R., Bragg-Gresham, J. L., Levin, N. W., Twardowski, Z. J., Wizemann, V., Saito, A., Kimata, N., Gillespie, B. W., Combe, C., Bommer, J., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000186 · Cited by 545
Shlipak, M. G., Katz, R., Sarnak, M. J., Fried, L. F., Newman, A. B., Stehman-Breen, C., Seliger, S. L., Kestenbaum, B., Psaty, B., Tracy, R. P., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00003 · Cited by 540
Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator
Weisbart, R. H., Golde, D. W., Clark, S. C., Wong, G. G., & Gasson, J. C. (1985) · Nature · doi:10.1038/314361a0 · Cited by 538
Rocco, M. V., Lockridge, R. S., Beck, G. J., Eggers, P. W., Gassman, J. J., Greene, T., Larive, B., Chan, C. T., Chertow, G. M., Copland, M., et al. (2011) · Kidney International · doi:10.1038/ki.2011.213 · Cited by 534
Effect of Online Hemodiafiltration on All-Cause Mortality and Cardiovascular Outcomes
Grooteman, M. P. C., van den Dorpel, M. A., Bots, M. L., Penne, E. L., van der Weerd, N. C., Mazairac, A. H. A., den Hoedt, C. H., van der Tweel, I., Lévesque, R., Nubé, M. J., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011121140 · Cited by 528
Miyata, T., van Ypersele de Strihou, C., Kurokawa, K., & Baynes, J. W. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00302.x · Cited by 518
Trimethylamine N-oxide: the good, the bad and the unknown.
Velasquez, M., Ramezani, A., Manal, A., & Raj, D. (2016) · Toxins · doi:10.3390/toxins8110326 · Cited by 504
β2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis
Smith, L. K., He, Y., Park, J.-S., Bieri, G., Snethlage, C. E., Lin, K., Gontier, G., Wabl, R., Plambeck, K. E., Udeochu, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3898 · Cited by 500 · cited 1×
“In a milestone study assessing functional neurologic changes during ageing, β2-microglobulin was identified as a pro-ageing factor, impairing hippocampal cognitive and regenerative function [333].”
BackgroundStomach regulates energy balance via acylated ghrelin and desacyl ghrelin
Asakawa, A., Inui, A., Fujimiya, M., Sakamaki, R., Shinfuku, N., Ueta, Y., Meguid, M. M., & Kasuga, M. (2005) · Gut · doi:10.1136/gut.2004.038737 · Cited by 483
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
Floege, J., Kim, J., Ireland, E., Chazot, C., Drueke, T., de Francisco, A., Kronenberg, F., Marcelli, D., Passlick-Deetjen, J., Schernthaner, G., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq219 · Cited by 477
Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
Ubbink, J., Vermaak, W., van der Merwe, A., & Becker, P. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.1.47 · Cited by 461
Jamison, R. L., Hartigan, P., Kaufman, J. S., Goldfarb, D. S., Warren, S. R., Guarino, P. D., Gaziano, J. M., & Veterans Affairs Site Investigators, F. T. (2007) · JAMA · doi:10.1001/jama.298.10.1163 · Cited by 456
Serum β-2 Microglobulin Levels Predict Mortality in Dialysis Patients: Results of the HEMO Study
Cheung, A. K., Rocco, M. V., Yan, G., Leypoldt, J. K., Levin, N. W., Greene, T., Agodoa, L., Bailey, J., Beck, G. J., Clark, W., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020132 · Cited by 453
Enkephalin may mediate euphoria and drive-reduction reward
BELLUZZI, J. D., & STEIN, L. (1977) · Nature · doi:10.1038/266556a0 · Cited by 450
Smith, F. R., & Goodman, D. S. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106741 · Cited by 447
Zoccali, C., Vanholder, R., Massy, Z. A., Ortiz, A., Sarafidis, P., Dekker, F. W., Fliser, D., Fouque, D., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 444
Self-citationIngrosso, D., Cimmino, A., Perna, A. F., Masella, L., De Santo, N. G., De Bonis, M. L., Vacca, M., D'Esposito, M., D'Urso, M., Galletti, P., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13372-7 · Cited by 427
Retinoid-binding proteins: mediators of retinoid action
NOY, N. (2000) · Biochemical Journal · doi:10.1042/bj3480481 · Cited by 422 · cited 1×
“Retinol binding proteins are not only transporters of retinoids but also function as regulators of retinoid metabolism and disposition [484].”
BackgroundColonic Contribution to Uremic Solutes
Aronov, P. A., Luo, F. J.-G., Plummer, N. S., Quan, Z., Holmes, S., Hostetter, T. H., & Meyer, T. W. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121220 · Cited by 422
Gryp, T., Vanholder, R., Vaneechoutte, M., & Glorieux, G. (2017) · Toxins · doi:10.3390/toxins9020052 · Cited by 417
Self-citationShalhoub, V., Shatzen, E. M., Ward, S. C., Davis, J., Stevens, J., Bi, V., Renshaw, L., Hawkins, N., Wang, W., Chen, C., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61405 · Cited by 413
Kielstein, J. T., Impraim, B., Simmel, S., Bode-Böger, S. M., Tsikas, D., Frölich, J. C., Hoeper, M. M., Haller, H., & Fliser, D. (2004) · Circulation · doi:10.1161/01.cir.0000105764.22626.b1 · Cited by 401
Warren, M. K., & Ralph, P. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.7.2281 · Cited by 384
Vaziri, N. D., Yuan, J., & Norris, K. (2013) · American Journal of Nephrology · doi:10.1159/000345969 · Cited by 381
Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule
Christensen, E. I., & Birn, H. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.4.f562 · Cited by 379
Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial
Rossi, M., Johnson, D. W., Morrison, M., Pascoe, E. M., Coombes, J. S., Forbes, J. M., Szeto, C.-C., McWhinney, B. C., Ungerer, J. P. J., & Campbell, K. L. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05240515 · Cited by 376
Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
Makita, Z., Bucala, R., Rayfield, E. J., Fuh, H., Manogue, K. R., Cerami, A., Viassara, H., Friedman, E. A., Kaufman, A. M., Korbet, S. M., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92935-1 · Cited by 373
Dezaki, K., Hosoda, H., Kakei, M., Hashiguchi, S., Watanabe, M., Kangawa, K., & Yada, T. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3142 · Cited by 366
A Role of Ghrelin in Neuroendocrine and Behavioral Responses to Stress in Mice
Asakawa, A., Inui, A., Kaga, T., Yuzuriha, H., Nagata, T., Fujimiya, M., Katsuura, G., Makino, S., Fujino, M. A., & Kasuga, M. (2001) · Neuroendocrinology · doi:10.1159/000054680 · Cited by 357
Mettang, T., & Kremer, A. E. (2014) · Kidney International · doi:10.1038/ki.2013.454 · Cited by 352
Miyata, T., Inagi, R., Iida, Y., Sato, M., Yamada, N., Oda, O., Maeda, K., & Seo, H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117002 · Cited by 345
The Cardiovascular Effect of the Uremic Solute Indole-3 Acetic Acid
Dou, L., Sallée, M., Cerini, C., Poitevin, S., Gondouin, B., Jourde-Chiche, N., Fallague, K., Brunet, P., Calaf, R., Dussol, B., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121283 · Cited by 329
ZOCCALI, C., MALLAMACI, F., BENEDETTO, F. A., TRIPEPI, G., PARLONGO, S., CATALIOTTI, A., CUTRUPI, S., GIACONE, G., BELLANUOVA, I., COTTINI, E., et al. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1271508 · Cited by 320
Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia
Sánchez-Lozada, L. G., Soto, V., Tapia, E., Avila-Casado, C., Sautin, Y. Y., Nakagawa, T., Franco, M., Rodríguez-Iturbe, B., & Johnson, R. J. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00104.2008 · Cited by 312
Speer, T., Rohrer, L., Blyszczuk, P., Shroff, R., Kuschnerus, K., Kränkel, N., Kania, G., Zewinger, S., Akhmedov, A., Shi, Y., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.009 · Cited by 310
Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy: A Randomized Controlled Trial
House, A. A., Eliasziw, M., Cattran, D. C., Churchill, D. N., Oliver, M. J., Fine, A., Dresser, G. K., & Spence, J. D. (2010) · JAMA · doi:10.1001/jama.2010.490 · Cited by 308
Palmer, B. F. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061381 · Cited by 303
Goicoechea, M., Garcia de Vinuesa, S., Verdalles, U., Verde, E., Macias, N., Santos, A., Pérez de Jose, A., Cedeño, S., Linares, T., & Luño, J. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.11.016 · Cited by 302
Moe, S. M., Chertow, G. M., Parfrey, P. S., Kubo, Y., Block, G. A., Correa-Rotter, R., Drüeke, T. B., Herzog, C. A., London, G. M., Mahaffey, K. W., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013876 · Cited by 302
Bode-Bo[Combining Diaeresis]ger, S. M., Scalera, F., Kielstein, J. T., Martens-Lobenhoffer, J., Breithardt, G. D., Fobker, M., & Reinecke, H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101119 · Cited by 302
Uric Acid and Cardiovascular Events: A Mendelian Randomization Study
Kleber, M. E., Delgado, G., Grammer, T. B., Silbernagel, G., Huang, J., Krämer, B. K., Ritz, E., & März, W. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070660 · Cited by 299
Randomised crossover trial of naltrexone in uraemic pruritus
Peer, G., Kivity, S., Agami, O., Fireman, E., Silverberg, D., Blum, M., & Iaina, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04176-1 · Cited by 295
Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.
Wu, X., Wakamiya, M., Vaishnav, S., Geske, R., Montgomery, C., Jones, P., Bradley, A., & Caskey, C. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.742 · Cited by 291
The pathogenesis and diagnosis of acute kidney injury in multiple myeloma
on behalf of the International Kidney and Monoclonal Gammopathy Research Group, Hutchison, C. A., Batuman, V., Behrens, J., Bridoux, F., Sirac, C., Dispenzieri, A., Herrera, G. A., Lachmann, H., & Sanders, P. W. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.168 · Cited by 289
PLASMA ENDOTHELIN LEVELS IN PATIENTS WITH URAEMIA
Koyama, H., Nishzawa, Y., Morii, H., Tabata, T., Inoue, T., & Yamaji, T. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92631-7 · Cited by 286
Kislinger, T., Tanji, N., Wendt, T., Qu, W., Lu, Y., Ferran, L. J., Taguchi, A., Olson, K., Bucciarelli, L., Goova, M., et al. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.905 · Cited by 285
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD
Schulman, G., Berl, T., Beck, G. J., Remuzzi, G., Ritz, E., Arita, K., Kato, A., & Shimizu, M. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010042 · Cited by 282
Hemodynamic, Renal, and Hormonal Effects of Ghrelin Infusion in Patients with Chronic Heart Failure
Nagaya, N. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5854 · Cited by 282
Uremic Toxicity: Present State of the Art
Vanholder, R., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., Dedeyn, P. P., Deppisch, R., Descamps-Latscha, B., Henle, T., et al. (2001) · The International Journal of Artificial Organs · doi:10.1177/039139880102401004 · Cited by 281
Self-citationDeficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
Norata, G. D., Marchesi, P., Pulakazhi Venu, V. K., Pasqualini, F., Anselmo, A., Moalli, F., Pizzitola, I., Garlanda, C., Mantovani, A., & Catapano, A. L. (2009) · Circulation · doi:10.1161/circulationaha.108.806547 · Cited by 277
Plasma Ghrelin and Desacyl Ghrelin Concentrations in Renal Failure
Yoshimoto, A., Mori, K., Sugawara, A., Mukoyama, M., Yahata, K., Suganami, T., Takaya, K., Hosoda, H., Kojima, M., Kangawa, K., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032420.12455.74 · Cited by 273
Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies
Leong, S., & Sirich, T. (2016) · Toxins · doi:10.3390/toxins8120358 · Cited by 272
Hutchison, C. A., Cockwell, P., Reid, S., Chandler, K., Mead, G. P., Harrison, J., Hattersley, J., Evans, N. D., Chappell, M. J., Cook, M., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080821 · Cited by 270
Removal of P-Cresol Sulfate by Hemodialysis
Martinez, A. W., Recht, N. S., Hostetter, T. H., & Meyer, T. W. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030310 · Cited by 262
Stanley, E. R., Cifone, M., Heard, P. M., & Defendi, V (1976) · The Journal of experimental medicine · doi:10.1084/jem.143.3.631 · Cited by 262
The role of asymmetric and symmetric dimethylarginines in renal disease
Schwedhelm, E., & Böger, R. H. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.31 · Cited by 260
Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
Tain, Y., & Hsu, C. (2017) · Toxins · doi:10.3390/toxins9030092 · Cited by 258
Sallée, M., Dou, L., Cerini, C., Poitevin, S., Brunet, P., & Burtey, S. (2014) · Toxins · doi:10.3390/toxins6030934 · Cited by 255
Gondouin, B., Cerini, C., Dou, L., Sallée, M., Duval-Sabatier, A., Pletinck, A., Calaf, R., Lacroix, R., Jourde-Chiche, N., Poitevin, S., et al. (2013) · Kidney International · doi:10.1038/ki.2013.133 · Cited by 253
Self-citationMicroscopic insights into the protein-stabilizing effect of trimethylamine N-oxide (TMAO)
Ma, J., Pazos, I. M., & Gai, F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403224111 · Cited by 252
Mishima, E., Fukuda, S., Mukawa, C., Yuri, A., Kanemitsu, Y., Matsumoto, Y., Akiyama, Y., Fukuda, N. N., Tsukamoto, H., Asaji, K., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.011 · Cited by 250
Barazzoni, R., Bosutti, A., Stebel, M., Cattin, M. R., Roder, E., Visintin, L., Cattin, L., Biolo, G., Zanetti, M., & Guarnieri, G. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00115.2004 · Cited by 249
Characterization of uremic toxin transport by organic anion transporters in the kidney
Deguchi, T., Kusuhara, H., Takadate, A., Endou, H., Otagiri, M., & Sugiyama, Y. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00354.x · Cited by 244
Uremic Toxicity of Advanced Glycation End Products in CKD
Stinghen, A. E. M., Massy, Z. A., Vlassara, H., Striker, G. E., & Boullier, A. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014101047 · Cited by 242
Barazzoni, R., Zanetti, M., Ferreira, C., Vinci, P., Pirulli, A., Mucci, M., Dore, F., Fonda, M., Ciocchi, B., Cattin, L., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2527 · Cited by 240
Pathophysiologic Effects of Uremic Retention Solutes
VANHOLDER, R., & DE SMET, R. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1081815 · Cited by 237
Self-citationChoi, Y., Yoon, Y., Lee, K., Hien, T. T., Kang, K. W., Kim, K., Lee, J., Lee, M., Lee, S. M., Kang, D., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-247148 · Cited by 235
Witko-Sarsat, V., Gausson, V., Nguyen, A.-T., Touam, M., Drüeke, T., Santangelo, F., & Descamps-Latscha, B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00044.x · Cited by 233
Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure
D’Apolito, M., Du, X., Zong, H., Catucci, A., Maiuri, L., Trivisano, T., Pettoello-Mantovani, M., Campanozzi, A., Raia, V., Pessin, J. E., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37672 · Cited by 233
Angiogenin: a review of the pathophysiology and potential clinical applications
TELLO‐MONTOLIU, A., PATEL, J. V., & LIP, G. Y. H. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01995.x · Cited by 229
Meinitzer, A., Seelhorst, U., Wellnitz, B., Halwachs-Baumann, G., Boehm, B. O., Winkelmann, B. R., & März, W. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.076711 · Cited by 227
Xue, M., Weickert, M. O., Qureshi, S., Kandala, N.-B., Anwar, A., Waldron, M., Shafie, A., Messenger, D., Fowler, M., Jenkins, G., et al. (2016) · Diabetes · doi:10.2337/db16-0153 · Cited by 213
Elevated Retinol-Binding Protein 4 Levels Are Associated with Metabolic Syndrome in Chinese People
Qi, Q., Yu, Z., Ye, X., Zhao, F., Huang, P., Hu, F. B., Franco, O. H., Wang, J., Li, H., Liu, Y., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1219 · Cited by 211
Poesen, R., Claes, K., Evenepoel, P., de Loor, H., Augustijns, P., Kuypers, D., & Meijers, B. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121302 · Cited by 209
Impact of hemodialysis duration on the removal of uremic retention solutes
Eloot, S., Van Biesen, W., Dhondt, A., Van de Wynkele, H., Glorieux, G., Verdonck, P., & Vanholder, R. (2008) · Kidney International · doi:10.1038/sj.ki.5002750 · Cited by 206
Self-citationCystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease
Menon, V., Shlipak, M. G., Wang, X., Coresh, J., Greene, T., Stevens, L., Kusek, J. W., Beck, G. J., Collins, A. J., Levey, A. S., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-1-200707030-00004 · Cited by 204
Carbamylation of Serum Albumin as a Risk Factor for Mortality in Patients with Kidney Failure
Berg, A. H., Drechsler, C., Wenger, J., Buccafusca, R., Hod, T., Kalim, S., Ramma, W., Parikh, S. M., Steen, H., Friedman, D. J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005218 · Cited by 200
Advanced glycation end products and mortality in hemodialysis patients
Schwedler, S. B., Metzger, T., Schinzel, R., & Wanner, C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00423.x · Cited by 195 · cited 1×
“Studies on the links between AGEs and mortality gave conflicting results, with some studies even showing better outcomes with higher AGE levels [188,189].”
ResultExpression of pentraxin 3 (PTX3) in human atherosclerotic lesions
Savchenko, A., Imamura, M., Ohashi, R., Jiang, S., Kawasaki, T., Hasegawa, G., Emura, I., Iwanari, H., Sagara, M., Tanaka, T., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2314 · Cited by 194
Wilson, A. M., Kimura, E., Harada, R. K., Nair, N., Narasimhan, B., Meng, X.-Y., Zhang, F., Beck, K. R., Olin, J. W., Fung, E. T., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.683722 · Cited by 192
Wu, D., Nishimura, N., Kuo, V., Fiehn, O., Shahbaz, S., Van Winkle, L., Matsumura, F., & Vogel, C. F. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.220202 · Cited by 187
de Loor, H., Bammens, B., Evenepoel, P., De Preter, V., & Verbeke, K. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.050781 · Cited by 186
Metabolite Profiling Identifies Markers of Uremia
Rhee, E. P., Souza, A., Farrell, L., Pollak, M. R., Lewis, G. D., Steele, D. J. R., Thadhani, R., Clish, C. B., Greka, A., & Gerszten, R. E. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009111132 · Cited by 184
Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review
Tsai, C.-W., Lin, S.-Y., Kuo, C.-C., & Huang, C.-C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170393 · Cited by 183
Polyamine Cytotoxicity in the Presence of Bovine Serum Amine Oxidase
Sharmin, S., Sakata, K., Kashiwagi, K., Ueda, S., Iwasaki, S., Shirahata, A., & Igarashi, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4569 · Cited by 182
Kalantar-Zadeh, K., Block, G., Humphreys, M. H., McAllister, C. J., & Kopple, J. D. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000107564.60018.51 · Cited by 182
Mechanism of increases in l-kynurenine and quinolinic acid in renal insufficiency
Saito, K., Fujigaki, S., Heyes, M. P., Shibata, K., Takemura, M., Fujii, H., Wada, H., Noma, A., & Seishima, M. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f565 · Cited by 182
Liu, J., Huang, K., Cai, G.-Y., Chen, X.-M., Yang, J.-R., Lin, L.-R., Yang, J., Huo, B.-G., Zhan, J., & He, Y.-N. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2013.10.002 · Cited by 181 · cited 1×
“AGEs bind to a number of receptors, among which advanced glycation end product-specific receptor (RAGE) plays a central role to impose several deleterious biological effects [170,171].”
BackgroundWikoff, W. R., Nagle, M. A., Kouznetsova, V. L., Tsigelny, I. F., & Nigam, S. K. (2011) · Journal of Proteome Research · doi:10.1021/pr200093w · Cited by 181
Descamps-Latscha, B., Witko-Sarsat, V., Nguyen-Khoa, T., Nguyen, A. T., Gausson, V., Mothu, N., London, G. M., & Jungers, P. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.09.011 · Cited by 181
Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients
Liabeuf, S., Lenglet, A., Desjardins, L., Neirynck, N., Glorieux, G., Lemke, H.-D., Vanholder, R., Diouf, M., Choukroun, G., & Massy, Z. A. (2012) · Kidney International · doi:10.1038/ki.2012.301 · Cited by 180
Self-citationThe Furan Fatty Acid Metabolite CMPF Is Elevated in Diabetes and Induces β Cell Dysfunction
Prentice, K. J., Luu, L., Allister, E. M., Liu, Y., Jun, L. S., Sloop, K. W., Hardy, A. B., Wei, L., Jia, W., Fantus, I. G., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.008 · Cited by 175
Endocrine abnormalities in patients undergoing long-term hemodialysis
Gómez, F., De La Cueva, R., Wauters, J.-P., & Lemarchand-Béraud, T. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90296-x · Cited by 173
Rabbani, N., Xue, M., & Thornalley, P. J. (2016) · Clinical Science · doi:10.1042/cs20160025 · Cited by 173
Bostom, A. G., Shemin, D., Lapane, K. L., Miller, J. W., Sutherland, P., Nadeau, M., Seyoum, E., Hartman, W., Prior, R., Wilson, P. W. F., et al. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05470-4 · Cited by 171
von Eynatten, M., Lepper, P. M., Liu, D., Lang, K., Baumann, M., Nawroth, P. P., Bierhaus, A., Dugi, K. A., Heemann, U., Allolio, B., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0743-8 · Cited by 171
Pedersen, E. R., Tuseth, N., Eussen, S. J. P. M., Ueland, P. M., Strand, E., Svingen, G. F. T., Midttun, Ø., Meyer, K., Mellgren, G., Ulvik, A., et al. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304674 · Cited by 170
Wen, Y.-D., Wang, H., Kho, S.-H., Rinkiko, S., Sheng, X., Shen, H.-M., & Zhu, Y.-Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053147 · Cited by 169
Tong, M., Carrero, J. J. A. A., Qureshi, A. R., Anderstam, B. D., Heimbu[Combining Diaeresis]rger, O., Ba[Combining Acute Accent]ra[Combining Acute Accent]ny, P., Axelsson, J., Alvestrand, A., Stenvinkel, P., Lindholm, B., et al. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00870207 · Cited by 167
Zuo, H., Ueland, P. M., Ulvik, A., Eussen, S. J. P. M., Vollset, S. E., Nygård, O., Midttun, Ø., Theofylaktopoulou, D., Meyer, K., & Tell, G. S. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv242 · Cited by 167
Protein Carbamylation Predicts Mortality in ESRD
Koeth, R., Kalantar‐Zadeh, K., Wang, Z., Fu, X., Tang, W. H. W., & Hazen, S. L. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012030254 · Cited by 165
Ok, E., Basnakian, A. G., Apostolov, E. O., Barri, Y. M., & Shah, S. V. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00391.x · Cited by 164
Zhou, G., Li, C., & Cai, L. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63254-3 · Cited by 164
Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily.
Saxena, S. K., Rybak, S. M., Davey, R. T., Youle, R. J., & Ackerman, E. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36710-9 · Cited by 163
Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow Conditions
Barth, M. C., Ahluwalia, N., Anderson, T. J. T., Hardy, G. J., Sinha, S., Alvarez-Cardona, J. A., Pruitt, I. E., Rhee, E. P., Colvin, R. A., & Gerszten, R. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024042 · Cited by 162
Colony-Stimulating Factor-1 Promotes Kidney Growth and Repair via Alteration of Macrophage Responses
Alikhan, M. A., Jones, C. V., Williams, T. M., Beckhouse, A. G., Fletcher, A. L., Kett, M. M., Sakkal, S., Samuel, C. S., Ramsay, R. G., Deane, J. A., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.037 · Cited by 162
Urea and chronic kidney disease: the comeback of the century? (in uraemia research)
Vanholder, R., Gryp, T., & Glorieux, G. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx039 · Cited by 162
Self-citationDrug protein binding in chronic renal failure: Evaluation of nine drugs
Vanholder, R., Van Landschoot, N., De Smet, R., Schoots, A., & Ringoir, S. (1988) · Kidney International · doi:10.1038/ki.1988.99 · Cited by 161
Self-citationUrea impairs β cell glycolysis and insulin secretion in chronic kidney disease
Koppe, L., Nyam, E., Vivot, K., Manning Fox, J. E., Dai, X.-Q., Nguyen, B. N., Trudel, D., Attané, C., Moullé, V. S., MacDonald, P. E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86181 · Cited by 161
Homocysteine and Hemostasis: Pathogenetic Mechanisms Predisposing to Thrombosis
Harpel, P. C., Zhang, X., & Borth, W. (1996) · The Journal of Nutrition · doi:10.1093/jn/126.suppl_4.1285s · Cited by 160
Metabolomic profiling of uremic solutes in CKD patients
Toyohara, T., Akiyama, Y., Suzuki, T., Takeuchi, Y., Mishima, E., Tanemoto, M., Momose, A., Toki, N., Sato, H., Nakayama, M., et al. (2010) · Hypertension Research · doi:10.1038/hr.2010.113 · Cited by 160
Dhaun, N., MacIntyre, I. M., Kerr, D., Melville, V., Johnston, N. R., Haughie, S., Goddard, J., & Webb, D. J. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.167486 · Cited by 160
van der Kloet, F. M., Tempels, F. W. A., Ismail, N., van der Heijden, R., Kasper, P. T., Rojas-Cherto, M., van Doorn, R., Spijksma, G., Koek, M., van der Greef, J., et al. (2012) · Metabolomics · doi:10.1007/s11306-011-0291-6 · Cited by 160
Xu, X., Qin, X., Li, Y., Sun, D., Wang, J., Liang, M., Wang, B., Huo, Y., Hou, F. F., & for the investigators of the Renal Substudy of the China Stroke Primary Prevention Trial (CSPPT) (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.4687 · Cited by 160
PROGRESS IN UREMIC TOXIN RESEARCH: Protein‐Bound Toxins—Update 2009
Jourde‐Chiche, N., Dou, L., Cerini, C., Dignat‐George, F., Vanholder, R., & Brunet, P. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00576.x · Cited by 159
Self-citationAdvanced glycation endproducts: from precursors to RAGE: round and round we go
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2012) · Amino Acids · doi:10.1007/s00726-010-0773-2 · Cited by 159
Farjo, K. M., Farjo, R. A., Halsey, S., Moiseyev, G., & Ma, J.-X. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00820-12 · Cited by 156
Odden, M. C., Amadu, A.-R., Smit, E., Lo, L. J., & Peralta, C. A. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.04.024 · Cited by 154
Pawlak, K., Domaniewski, T., Myśliwiec, M., & Pawlak, D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.014 · Cited by 151
The Gut: The Forgotten Organ in Uremia?
Schepers, E., Glorieux, G., & Vanholder, R. (2010) · Blood Purification · doi:10.1159/000245639 · Cited by 150
Self-citationVanholder, R., Smet, R. D., Waterloos, M.-A. F., Landschoot, N. V., Vogeleere, P., Hoste, E. A. J., & Ringoir, S. (1995) · Kidney International · doi:10.1038/ki.1995.64 · Cited by 150
Self-citationThe colony-stimulating factors and cancer
Metcalf, D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2843 · Cited by 149
FGF-23 and secondary hyperparathyroidism in chronic kidney disease
Silver, J., & Naveh‐Many, T. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.147 · Cited by 147
Carrero, J. J., Kyriazis, J., Sönmez, A., Tzanakis, I. P., Qureshi, A. R., Stenvinkel, P., Sağlam, M., Stylianou, K., Yaman, H., Taşlıpınar, A., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06840711 · Cited by 147
Mechanisms and consequences of carbamoylation
Delanghe, S. E., Delanghe, J., Speeckaert, R., Biesen, W. V., & Speeckaert, M. M. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.103 · Cited by 147
Urea-induced ROS cause endothelial dysfunction in chronic renal failure
D’Apolito, M., Du, X., Pisanelli, D., Pettoello‐Mantovani, M., Campanozzi, A., Giacco, F., Maffione, A. B., Colia, A. L., Brownlee, M., & Giardino, I. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.034 · Cited by 146
Mutsaers, H. A. M., van den Heuvel, L. P., Ringens, L. H. J., Dankers, A. C. A., Rüssel, F. G. M., Wetzels, J. F. M., Hoenderop, J. G. J., & Masereeuw, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018438 · Cited by 146
Alexander, K. S., Wu, H.-Q., Schwarcz, R., & Bruno, J. P. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2539-2 · Cited by 142
Heinz, J., Kropf, S., Domröse, U., Westphal, S., Borucki, K., Luley, C., Neumann, K. H., & Dierkes, J. (2010) · Circulation · doi:10.1161/circulationaha.109.904672 · Cited by 142
Symmetric Dimethylarginine as a Proinflammatory Agent in Chronic Kidney Disease
Schepers, E., Barreto, D. V., Liabeuf, S., Glorieux, G., Eloot, S., Barreto, F. C., Massy, Z., & Vanholder, R. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01720211 · Cited by 142
Self-citationModified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins
Florens, N., Calzada, C., Lyasko, E., Juillard, L., & Soulage, C. O. (2016) · Toxins · doi:10.3390/toxins8120376 · Cited by 142
Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression
Jankowski, J., van der Giet, M., Jankowski, V., Schmidt, S. C., Hemeier, M., Mahn, B., Giebing, G., Tölle, M., Luftmann, H., Schlüter, H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15524 · Cited by 140
Papanastasiou, P., Grass, L., Rodela, H., Patrikarea, A., Oreopoulos, D. G., & Diamandis, E. P. (1994) · Kidney International · doi:10.1038/ki.1994.262 · Cited by 139
RAGE and the pathogenesis of chronic kidney disease
D’Agati, V. D., & Schmidt, A. M. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.54 · Cited by 139
Urea, a true uremic toxin: the empire strikes back
Lau, W. L., & Vaziri, N. D. (2016) · Clinical Science · doi:10.1042/cs20160203 · Cited by 139
Busch, M., Franke, S., Müller, A., Wolf, M., Gerth, J., Ott, U., Niwa, T., & Stein, G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00736.x · Cited by 136
Clinical management of the uraemic syndrome in chronic kidney disease
Vanholder, R., Fouque, D. P., Glorieux, G., Heine, G. H., Kanbay, M., Mallamaci, F., Massy, Z. A., Ortíz, A., Rossignol, P., Więcek, A., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00033-4 · Cited by 136
Self-citationPhysiology of Endothelin and the Kidney
Kohan, D. E., Inscho, E. W., Wesson, D. E., & Pollock, D. M. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100039 · Cited by 134
Taki, K., Takayama, F., Tsuruta, Y., & Niwa, T. (2006) · Kidney International · doi:10.1038/sj.ki.5000330 · Cited by 133
Carrero, J. J., Aguilera, A., Stenvinkel, P., Gil, F., Selgas, R., & Lindholm, B. (2007) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2007.10.022 · Cited by 132
PROGRESS IN UREMIC TOXIN RESEARCH: Guanidino Compounds as Uremic (Neuro)Toxins
De Deyn, P. P., Vanholder, R., Eloot, S., & Glorieux, G. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00577.x · Cited by 131
Self-citationHou, S., Grossman, S. D., & Molitch, M. E. (1985) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(85)80181-5 · Cited by 130
Aguilera, A. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.6.1476 · Cited by 130
Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxin-sensitive G protein.
Kassis, S., Olasmaa, M., Terenius, L., & Fishman, P. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61367-5 · Cited by 129
Metabolism of complement factor D in renal failure
Pascual, M. A., Steiger, G., Estreicher, J., Macon, K. J., Volanakis, J. E., & Schifferli, J. A. (1988) · Kidney International · doi:10.1038/ki.1988.214 · Cited by 128
Free immunoglobulin light chain: Its biology and implications in diseases
Nakano, T., Matsui, M., Inoue, I., Awata, T., Katayama, S., & Murakoshi, T. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.03.007 · Cited by 128
Imani, F., Horii, Y., Suthanthiran, M., Skolnik, E. Y., Makita, Z., Sharma, V, Sehajpal, P., & Vlassara, H. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2165 · Cited by 128
Meert, N., Schepers, E., Glorieux, G., Landschoot, M. V., Goeman, J., Waterloos, M., Dhondt, A., der Eycken, J. V., & Vanholder, R. C. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr672 · Cited by 127
Self-citationServettaz, A., Guilpain, P., Goulvestre, C., Chéreau, C., Hercend, C., Nicco, C., Guillevin, L., Weill, B. J., Mouthon, L., & Batteux, F. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.067504 · Cited by 126
Concurrent and robust regulation of feeding behaviors and metabolism by orexin neurons
Inutsuka, A., Inui, A., Tabuchi, S., Tsunematsu, T., Lazarus, M., & Yamanaka, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.06.015 · Cited by 126
Adrenomedullin and endothelial barrier function
Temmesfeld‐Wollbrück, B., Hocke, A. C., Suttorp, N., & Hippenstiel, S. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-02-0128 · Cited by 126
Ayala, E. R., Pecoits-Filho, R., Heimbürger, O., Lindholm, B., Nordfors, L., & Stenvinkel, P. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg559 · Cited by 126
Mutsaers, H. A. M., Wilmer, M. J. G., Reijnders, D., Jansen, J., van den Broek, P. H. H., Forkink, M., Schepers, E., Glorieux, G., Vanholder, R. C., van den Heuvel, L. P., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.006 · Cited by 123
Self-citationEndothelin antagonists for diabetic and non‐diabetic chronic kidney disease
Kohan, D. E., & Pollock, D. M. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12064 · Cited by 122
Heinz, J., Kropf, S., Luley, C. H., & Dierkes, J. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.01.266 · Cited by 122
Josson, S., Nomura, T., Lin, J., Huang, W., Wu, D., Zhau, H. E., Zayzafoon, M., Weizmann, M. N., Gururajan, M., & Chung, L. W. K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3382 · Cited by 122
Bostom, A. G., Shemin, D. G., Lapane, K. L., Nadeau, M., Sutherland, P. A., Chan, J. A.-W., Rozen, R. R., Yoburn, D. C., Jacques, P. F., Selhub, J., et al. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05809-1 · Cited by 121
Uremic Toxins Overload Accelerates Renal Damage in a Rat Model of Chronic Renal Failure
Satoh, M., Hayashi, H., WATANABE, M., Ueda, K., Yamato, H., Yoshioka, T., & Motojima, M. (2003) · Nephron Experimental Nephrology · doi:10.1159/000074327 · Cited by 121
Donadio, C., Lucchesi, A., Ardini, M., & Giordani, R. (2001) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(00)00550-1 · Cited by 120
Shi, X., Hou, F. F., Niu, H. X., Wang, G. B., Xie, D., Guo, Z. J., Zhou, Z. M., Yang, F., Tian, J. W., & Zhang, X. (2008) · Endocrinology · doi:10.1210/en.2007-1544 · Cited by 120
Eloot, S., Torremans, A., Smet, R. D., Marescau, B., Wachter, D. D., Deyn, P. P. D., Lameire, N. H., Verdonck, P., & Vanholder, R. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00238.x · Cited by 119
Self-citation
Cited by
Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment
Gherghina, M.-E., Peride, I., Tiglis, M., Neagu, T. P., Niculae, A., & Checherita, I. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063188 · Cited by 501
Chronic inflammation in end-stage renal disease and dialysis
Cobo, G., Lindholm, B., & Stenvinkel, P. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy175 · Cited by 439
Lim, Y. J., Sidor, N. A., Tonial, N. C., Che, A., & Urquhart, B. L. (2021) · Toxins · doi:10.3390/toxins13020142 · Cited by 373
Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease
Podkowińska, A., & Formanowicz, D. (2020) · Antioxidants · doi:10.3390/antiox9080752 · Cited by 356
Classification of Uremic Toxins and Their Role in Kidney Failure
Rosner, M. H., Reis, T., Husain-Syed, F., Vanholder, R., Hutchison, C., Stenvinkel, P., Blankestijn, P. J., Cozzolino, M., Juillard, L., Kashani, K., et al. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02660221 · Cited by 291
Self-citation
Metadata
- Authors
- Vanholder, R., Pletinck, A., Schepers, E., & Glorieux, G.
- Venue
- Toxins
- Publisher
- MDPI AG
- Published
- 2018-01-08
- Volume
- 10
- Issue
- 1
- Pages
- 33
- ISSN
- 2072-6651 (ISSN-L)
- OpenAlex
- W2783756307
- Cited by
- 356
- References
- 396
- FWCI
- 27.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.